Somatic mutations of beta2-microglobulin are correlated with a lack of disease recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial
Main Authors: | , , , , , , , , , , |
---|---|
格式: | Conference item |
出版: |
Wiley
2018
|